Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided 5% dextrose versus methylprednisolone injection for mild to moderate carpal tunnel syndrome
IRCT20250810066808N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dextrose and methylprednisolone in carpal tunnel syndrome (CTS) (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: Pain intensity by Visual Analog Scale at 4 months and Boston Carpal Tunnel Questionnaire score at 4 months. Started Aug 2025; status: completed.
02
Drugs
dextrosemethylprednisolone
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on IRCT20250810066808N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250810066808N1.